je.st
news
Home
› Analyst Update: Bristol-Myers Squibb Co, Achillion Pharmaceuticals, Inc., and Kimberly Clark Corp
Analyst Update: Bristol-Myers Squibb Co, Achillion Pharmaceuticals, Inc., and Kimberly Clark Corp
2014-12-24 16:05:09| Paper - Topix.net
Bristol-Myers Squibb Co has been on a tear recently , outperforming the S&P 500 Index by more than 12 percentage points in the last 60 sessions. However, despite this morning's positive attention -- and the fact it touched a 13-year high of $61.77 out of the gate -- BMY has followed its pharmaceutical peers into the red , last seen at $58.74.
Tags: update
corp
clark
analyst
Category:Materials
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||